An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis

Condition:   Primary Biliary CirrhosisIntervention:   Drug: LUM001Sponsor:   Lumena Pharmaceuticals, Inc.Not yet recruiting - verified December 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials